CALC Stock Analysis: Buy, Sell, or Hold?
CALC - CalciMedica, Inc. Common Stock
$0.85
0.05 (6.21%)
▲
5d:
+14.18%
30d:
+45.26%
90d:
+36.25%
WAIT
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When CALC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: CALC is 11.9% above its trading range ($0.76). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: CALC is 11.9% above its trading range ($0.76). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: CALC is currently trading at $0.85, which is considered extended relative to its 30-day fair value range of $0.58 to $0.76.
Technical Outlook: Technically, CALC is in a downtrend. Immediate support is located at $0.61, while resistance sits at $0.92. The stock is showing strong short-term momentum, up 6.2% recently.
Market Sentiment: CALC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (17th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $10.33 (+1115.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CALC is in a downtrend. Immediate support is located at $0.61, while resistance sits at $0.92. The stock is showing strong short-term momentum, up 6.2% recently.
Market Sentiment: CALC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (17th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $10.33 (+1115.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.58 -
$0.76
Company Quality Score
61/100
(BUY)
Options IV Signal
17th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BEARISH: Price significantly overextended (+11.9% above its trading range)
- BULLISH: Options cheap (IV 17th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.2%)
- BULLISH: Trading 1115.4% below Wall St target ($10.33)
- WARNING: Recommendation downgraded due to 11.9% overvaluation
Trading Range Analysis
30-Day Trading Range
$0.58 -
$0.76
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$0.25
(29.4%)
Support & Resistance Levels
Support Level
$0.61
Resistance Level
$0.92
Current Trend
Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.43
Wall Street Target
$10.33
(+1115.4%)
Share & Embed Analysis
Last updated: June 03, 2026 10:06 PM ET
Data refreshes hourly during market hours. Next update: 11:06 PM
Data refreshes hourly during market hours. Next update: 11:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CALC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$55 | 66 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 58 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 53 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 55 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 53 HOLD |
